| Active ingredients | | Date of last message | Type of reason | AM designation |
| Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) | Change notification | 12.12.2025 | Other | Ferrlecit 40 mg |
| Clomipramine hydrochloride | Initial report | 12.12.2025 | Other | Clomipramine-neuraxpharm 75 mg retard |
| Epoetin zeta | Initial report | 12.12.2025 | Other | Retacrit 40,000 IU/1 ml solution for injection in pre-filled syringe |
| Epoetin zeta | Initial report | 12.12.2025 | Other | Retacrit 40,000 IU/1 ml solution for injection in pre-filled syringe |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Initial report | 11.12.2025 | Other | Atorvastatin Micro Labs 10 mg film-coated tablets |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 11.12.2025 | Other | Atorvastatin Micro Labs 30 mg film-coated tablets |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 11.12.2025 | Other | Atorvastatin Micro Labs 60 mg film-coated tablets |
| Fluoxetine hydrochloride | Change notification | 11.12.2025 | Other | Fluoxetine Micro Labs 60 mg hard capsules |
| Fluoxetine hydrochloride | Change notification | 11.12.2025 | Other | Fluoxetine Micro Labs 30 mg hard capsules |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 11.12.2025 | Other | Quetiapine AL 200 mg prolonged-release tablets |
| Prednicarbate | Change notification | 11.12.2025 | Other | Prednicarbate acis solution |
| Zoledronic acid monohydrate | Initial report | 11.12.2025 | Other | Zoledronic acid AL 4 mg/100 ml infusion solution |
| Ibandronate sodium monohydrate | Initial report | 11.12.2025 | Other | Ibandronic acid AL 3 mg solution for injection in a pre-filled syringe |
| Fibrinogen, human | Initial report | 10.12.2025 | Other | Fibryga |
| Sodium (hydrocortisone-21-succinate) | Change notification | 10.12.2025 | Production problem | Hydrocortisone PANPHARMA 100 mg |
| Methylphenidate hydrochloride | Change notification | 10.12.2025 | Other | CONCERTA 54 mg prolonged-release tablets |
| Methylphenidate hydrochloride | Change notification | 10.12.2025 | Other | CONCERTA 36 mg prolonged-release tablets |
| Methylphenidate hydrochloride | Change notification | 10.12.2025 | Other | CONCERTA 27 mg prolonged-release tablets |
| Methylphenidate hydrochloride | Change notification | 10.12.2025 | Other | CONCERTA 18 mg prolonged-release tablets |
| Dimenhydrinate | Initial report | 10.12.2025 | Production problem | Dimenhydrinate PANPHARMA 6.2 mg/ml solution for injection (i.v.) |
| Metformin hydrochloride | Initial report | 10.12.2025 | Other | Metformin 500 – 1 A Pharma |
| Candesartan cilexetil | Initial report | 10.12.2025 | Other | Blopress 16 mg |
| Colistimethate sodium | Initial report | 10.12.2025 | Production problem | Colistin CF |
| Risperidone | Change notification | 10.12.2025 | Production problem | Risperidone-ratiopharm 50 mg powder and solvent for the preparation of a depot injection suspension |
| Risperidone | Change notification | 10.12.2025 | Production problem | Risperidone-ratiopharm 37.5 mg powder and solvent for the preparation of a depot injection suspension |
| Risperidone | Change notification | 10.12.2025 | Production problem | Risperidone-ratiopharm 25 mg powder and solvent for the preparation of a depot injection suspension |
| Ribavirin | Change notification | 10.12.2025 | Production problem | Ribavirin-ratiopharm 200 mg film-coated tablets |
| Ribavirin | Change notification | 10.12.2025 | Other | Ribavirin-ratiopharm 400 mg film-coated tablets |
| Levothyroxine sodium | Initial report | 10.12.2025 | Other | L-thyroxine-Na-ratiopharm 50 microgram tablets |
| Levothyroxine sodium | Initial report | 10.12.2025 | Other | L-Thyroxine-Na-ratiopharm 25 microgram tablets |
| Isoniazid; pyridoxine hydrochloride | Initial report | 09.12.2025 | Other | Isozid comp. 200 mg N |
| Isoniazid | Initial report | 09.12.2025 | Other | Isozid 0.5 N |
| Pyrazinamide | Initial report | 09.12.2025 | Production problem | Pyrafat 500mg |
| Dapsone | Initial report | 09.12.2025 | Production problem | Dapson-Fatol |
| Filgrastim | Initial report | 09.12.2025 | Other | Nivestim 12 million E/0.2 ml injection/infusion solution – OP (5×0.2 ml) |
| Adalimumab | Initial report | 09.12.2025 | Other | Amsparity |
| Adalimumab | Initial report | 09.12.2025 | Other | Amsparity |
| Adalimumab | Initial report | 09.12.2025 | Other | Amsparity |
| Adalimumab | Initial report | 09.12.2025 | Other | Amsparity |
| Risedronate sodium 2.5 hydrate (Ph.Eur.) | Initial report | 09.12.2025 | Other | Risedronate Aurobindo once weekly 35 mg film-coated tablets |
| Terazosin hydrochloride dihydrate | Change notification | 09.12.2025 | Other | Heitrin 1mg |
| Terazosin hydrochloride dihydrate | Change notification | 09.12.2025 | Other | Heitrin 5mg |
| Terazosin hydrochloride dihydrate | Change notification | 09.12.2025 | Other | Heitrin 2 mg |
| Metamizole sodium monohydrate | Initial report | 08.12.2025 | Production problem | Novaminsulfon – 1 A Pharma Drops |
| Methylphenidate hydrochloride | Initial report | 08.12.2025 | Other | Equasym Retard 40 mg hard capsules with modified release |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Initial report | 08.12.2025 | Other | Atorvastatin – 1A Pharma 40 mg film-coated tablets |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Initial report | 08.12.2025 | Other | Atorvastatin – 1A Pharma 10 mg film-coated tablets |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 08.12.2025 | Other | Seroquel Prolong 50 mg prolonged-release tablets |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 08.12.2025 | Other | Seroquel Prolong 300 mg prolonged-release tablets |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 08.12.2025 | Other | Seroquel Prolong 200 mg prolonged-release tablets |